Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy

BACKGROUND: We aimed to assess the efficacy and safety of erenumab, a fully human monoclonal antibody inhibiting the calcitonin gene-related peptide receptor (CGRPr), for the prevention of migraine in a real-life setting. MAIN BODY: We included in our observational study all patients with episodic o...

Full description

Saved in:
Bibliographic Details
Published in:J Headache Pain
Main Authors: Ornello, Raffaele, Casalena, Alfonsina, Frattale, Ilaria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Viola, Stefano, Cerone, Davide, Marini, Carmine, Pistoia, Francesca, Sacco, Simona
Format: Artigo
Language:Inglês
Published: Springer Milan 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7137484/
https://ncbi.nlm.nih.gov/pubmed/32264820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-020-01102-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items